• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通人群中常见的BRCA1基因变异与乳腺癌和卵巢癌易感性

Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

作者信息

Dunning A M, Chiano M, Smith N R, Dearden J, Gore M, Oakes S, Wilson C, Stratton M, Peto J, Easton D, Clayton D, Ponder B A

机构信息

CRC Human Cancer Genetics Research Group, Addenbrooke's Hospital, Cambridge, UK.

出版信息

Hum Mol Genet. 1997 Feb;6(2):285-9. doi: 10.1093/hmg/6.2.285.

DOI:10.1093/hmg/6.2.285
PMID:9063749
Abstract

Most multiple case families of young onset breast cancer and ovarian cancer are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2. However, these mutations are uncommon in the population and they probably account for only a few percent of all breast cancer incidence. A much larger fraction of breast cancer might, in principle, be due to common variants which confer more modest individual risks. There are several common polymorphisms in the BRCA1 gene which generate amino acid substitutions. We have examined the frequency of four of these polymorphisms: Gln356Arg, Pro871Leu, Glu1038Gly and Ser1613Gly in large series of breast and ovarian cancer cases and matched controls. Due to strong linkage disequilibrium, these four sites generate only three haplotypes with a frequency > 1.3%. The most common haplotypes, defined by the alleles Gln356Pro871Glu1038Ser1613 and Gln356Leu871Gly1038Gly1613, have frequencies of 0.57 and 0.32 respectively, and these frequencies do not differ significantly between patient and control groups. Thus the most common polymorphisms of the BRCA1 gene do not make a significant contribution to breast or ovarian cancer risk. However, our data suggest that the Arg356 allele may have a different genotype distribution in breast cancer patients from that in controls (Arg356 homozygotes are more frequent in the control groups, P = 0.01), indicating that it may be protective against breast cancer. If this finding can be confirmed, it may provide an insight into the structural features of the BRCA1 protein that are important for its function.

摘要

大多数年轻女性乳腺癌和卵巢癌的多病例家族被认为是由易感基因BRCA1和BRCA2中的高外显率突变所致。然而,这些突变在人群中并不常见,它们可能仅占所有乳腺癌发病率的百分之几。原则上,更大比例的乳腺癌可能是由具有较低个体风险的常见变异引起的。BRCA1基因存在几种常见的多态性,这些多态性会导致氨基酸替换。我们在大量乳腺癌和卵巢癌病例以及匹配的对照组中检测了其中四种多态性的频率:Gln356Arg、Pro871Leu、Glu1038Gly和Ser1613Gly。由于强连锁不平衡,这四个位点仅产生三种频率>1.3%的单倍型。最常见的单倍型由等位基因Gln356Pro871Glu1038Ser1613和Gln356Leu871Gly1038Gly1613定义,频率分别为0.57和0.32,患者组和对照组之间这些频率无显著差异。因此,BRCA1基因最常见的多态性对乳腺癌或卵巢癌风险没有显著贡献。然而,我们的数据表明,Arg356等位基因在乳腺癌患者中的基因型分布可能与对照组不同(对照组中Arg356纯合子更常见,P = 0.01),这表明它可能对乳腺癌具有保护作用。如果这一发现能够得到证实,可能会为深入了解BRCA1蛋白对其功能至关重要的结构特征提供线索。

相似文献

1
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.普通人群中常见的BRCA1基因变异与乳腺癌和卵巢癌易感性
Hum Mol Genet. 1997 Feb;6(2):285-9. doi: 10.1093/hmg/6.2.285.
2
Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.BRCA1和BRCA2基因的错义多态性与乳腺癌和卵巢癌风险
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2339-42. doi: 10.1158/1055-9965.EPI-09-0447.
3
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.对来自乳腺癌-卵巢癌家族的BRCA1和BRCA2阴性先证者、早发性乳腺癌病例及对照个体中与BRCA1相互作用的基因ZNF350/ZBRK1和BRIP1/BACH1进行突变分析。
Hum Mutat. 2003 Aug;22(2):121-8. doi: 10.1002/humu.10238.
4
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.西班牙东南部穆尔西亚地区遗传性乳腺癌和卵巢癌家族中BRCA1/BRCA2基因变异的分子特征及临床解读:BRCA携带者和非携带者的临床病理特征
Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x.
5
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.MDM2基因单核苷酸多态性309加速了犹太裔阿什肯纳兹血统的BRCA1和BRCA2携带者的乳腺癌和卵巢癌发生。
Breast Cancer Res Treat. 2008 Oct;111(3):497-504. doi: 10.1007/s10549-007-9797-z. Epub 2007 Nov 18.
6
Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.高危非BRCA1/2法裔加拿大乳腺癌和卵巢癌家族中ZBRK1/ZNF350基因的遗传变异和单倍型分析
Int J Cancer. 2008 Jan 1;122(1):108-16. doi: 10.1002/ijc.23058.
7
The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor.BRCA1基因3'-非翻译区:5711 + 421T/T_5711 + 1286T/T基因型是一种可能的乳腺癌和卵巢癌风险因素。
Genet Test Mol Biomarkers. 2009 Jun;13(3):307-17. doi: 10.1089/gtmb.2008.0127.
8
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2突变的阿什肯纳兹犹太女性患卵巢癌的风险。
Clin Cancer Res. 2002 Dec;8(12):3776-81.
9
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.KLOTHO 功能变体:阿什肯纳兹裔 BRCA1 突变携带者的乳腺癌风险修饰因子。
Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5.
10
Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.泰国家族性和散发性早发性乳腺癌及卵巢癌中乳腺癌易感基因BRCA1和BRCA2的分析
Hum Mutat. 2002 Sep;20(3):230. doi: 10.1002/humu.9049.

引用本文的文献

1
The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury.个体对刺突蛋白损伤易感性的可能机制基础。
Adv Virol. 2025 Jun 24;2025:7990876. doi: 10.1155/av/7990876. eCollection 2025.
2
Association Between Seven Selected Genetic Polymorphisms in DNA Repair-Related Genes and Breast Cancer Risk: Evidence from a Comprehensive Meta-analysis Including 96 Studies.DNA修复相关基因中七个选定基因多态性与乳腺癌风险之间的关联:来自一项包含96项研究的综合荟萃分析的证据。
Biochem Genet. 2025 Jun 30. doi: 10.1007/s10528-025-11181-5.
3
Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
BRCA1(rs1799950)、BRCA2(rs144848)和 TP53(rs1042522)多态性与巴基斯坦开伯尔-普赫图赫瓦省帕坦族乳腺癌风险的显著关联。
Mol Biol Rep. 2023 Jul;50(7):6087-6096. doi: 10.1007/s11033-023-08463-9. Epub 2023 Jun 10.
4
Association between BRCA1 polymorphisms rs799917 and rs1799966 and breast cancer risk: a meta-analysis.BRCA1基因多态性rs799917和rs1799966与乳腺癌风险的关联:一项荟萃分析。
J Int Med Res. 2019 Apr;47(4):1409-1416. doi: 10.1177/0300060519826819. Epub 2019 Mar 5.
5
and Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan.哈萨克斯坦散发性乳腺癌患者的基因 突变筛查
Cent Asian J Glob Health. 2013 May 21;2(1):29. doi: 10.5195/cajgh.2013.29. eCollection 2013.
6
The association between BRCA1 gene polymorphism and cancer risk: a meta-analysis.BRCA1基因多态性与癌症风险的关联:一项荟萃分析。
Oncotarget. 2018 Jan 6;9(9):8681-8694. doi: 10.18632/oncotarget.24064. eCollection 2018 Feb 2.
7
Association between BRCA1 P871L polymorphism and cancer risk: evidence from a meta-analysis.BRCA1基因P871L多态性与癌症风险之间的关联:一项荟萃分析的证据
Oncotarget. 2017 May 2;8(18):30587-30594. doi: 10.18632/oncotarget.15739.
8
Rapid evolution of BRCA1 and BRCA2 in humans and other primates.BRCA1 和 BRCA2 在人类和其他灵长类动物中的快速进化。
BMC Evol Biol. 2014 Jul 11;14:155. doi: 10.1186/1471-2148-14-155.
9
Inherited and acquired alterations in development of breast cancer.乳腺癌发生过程中的遗传和后天改变。
Appl Clin Genet. 2011 Nov 14;4:145-58. doi: 10.2147/TACG.S13226. Print 2011.
10
BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.BRCA1 多态性与西纽约暴露与乳腺癌(WEB)研究中的乳腺癌流行病学。
Genet Epidemiol. 2013 Jul;37(5):504-11. doi: 10.1002/gepi.21730. Epub 2013 May 14.